These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 27031121

  • 1. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
    Wichmann S, Færk G, Bundgaard JR, Gätke MR.
    Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
    [Abstract] [Full Text] [Related]

  • 2. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
    Gätke MR, Bundgaard JR, Viby-Mogensen J.
    Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
    [Abstract] [Full Text] [Related]

  • 3. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ, Gätke MR.
    Ugeskr Laeger; 2015 Apr 27; 177(18):866-8. PubMed ID: 26539575
    [Abstract] [Full Text] [Related]

  • 4. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ, Gätke MR.
    Ugeskr Laeger; 2014 Mar 17; 176(12A):. PubMed ID: 25350885
    [Abstract] [Full Text] [Related]

  • 5. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J, Staehr-Rye AK, Nielsen CV, Gätke MR.
    Acta Anaesthesiol Scand; 2014 Sep 17; 58(8):1040-3. PubMed ID: 24947746
    [Abstract] [Full Text] [Related]

  • 6. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
    Cerf C, Mesguish M, Gabriel I, Amselem S, Duvaldestin P.
    Anesth Analg; 2002 Feb 17; 94(2):461-6, table of contents. PubMed ID: 11812719
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
    Delacour H, Lushchekina S, Mabboux I, Ceppa F, Masson P, Schopfer LM, Lockridge O.
    Biochem Pharmacol; 2014 Dec 01; 92(3):476-83. PubMed ID: 25264279
    [Abstract] [Full Text] [Related]

  • 8. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
    Kanyamibwa D, Tsaousi G, Karakoulas K, Thomareis O, Parlapani A, Makedou AH, Giala M.
    Methods Find Exp Clin Pharmacol; 2008 Apr 01; 30(3):187-91. PubMed ID: 18597002
    [Abstract] [Full Text] [Related]

  • 9. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.
    Levano S, Ginz H, Siegemund M, Filipovic M, Voronkov E, Urwyler A, Girard T.
    Anesthesiology; 2005 Mar 01; 102(3):531-5. PubMed ID: 15731589
    [Abstract] [Full Text] [Related]

  • 10. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
    Mintjens N, Brummans R, Soetens F, Claes KBM, Vanlinthout LE.
    Acta Anaesthesiol Scand; 2021 Feb 01; 65(2):182-187. PubMed ID: 33010031
    [Abstract] [Full Text] [Related]

  • 11. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.
    Gätke MR, Ostergaard D, Bundgaard JR, Varin F, Viby-Mogensen J.
    Anesthesiology; 2001 Sep 01; 95(3):600-6. PubMed ID: 11575530
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
    Delacour H, Lushchekina S, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P.
    PLoS One; 2014 Sep 01; 9(7):e101552. PubMed ID: 25054547
    [Abstract] [Full Text] [Related]

  • 13. Effect of succinylcholine on subsequently administered mivacurium in children.
    Jalkanen L, Meretoja OA, Taivainen T.
    Acta Anaesthesiol Scand; 1995 Nov 01; 39(8):1024-7. PubMed ID: 8607302
    [Abstract] [Full Text] [Related]

  • 14. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
    Mollerup HM, Gätke MR.
    Acta Anaesthesiol Scand; 2011 Jan 01; 55(1):82-6. PubMed ID: 21029050
    [Abstract] [Full Text] [Related]

  • 15. The continuing search for a succinylcholine replacement.
    Caldwell JE.
    Anesthesiology; 2004 Apr 01; 100(4):763-4. PubMed ID: 15087607
    [No Abstract] [Full Text] [Related]

  • 16. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
    Mabboux I, Hary B, Courcelle S, Ceppa F, Delacour H.
    Arch Pediatr; 2016 May 01; 23(5):497-500. PubMed ID: 27017361
    [Abstract] [Full Text] [Related]

  • 17. Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.
    Gätke MR, Viby-Mogensen J, Ostergaard D, Bundgaard JR.
    Anesthesiology; 2005 Mar 01; 102(3):503-8. PubMed ID: 15731585
    [Abstract] [Full Text] [Related]

  • 18. [Prolonged curarization with mivacurium and suxamethonium: will molecular biology allow a diagnostic and therapeutic approach?].
    Duvaldestin P.
    Ann Fr Anesth Reanim; 1995 Mar 01; 14(6):465-6. PubMed ID: 8745968
    [No Abstract] [Full Text] [Related]

  • 19. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
    Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM.
    Clin Chem; 2003 Aug 01; 49(8):1297-308. PubMed ID: 12881446
    [Abstract] [Full Text] [Related]

  • 20. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
    Bretlau C, Sørensen MK, Vedersoe AL, Rasmussen LS, Gätke MR.
    Anesth Analg; 2013 Mar 01; 116(3):596-601. PubMed ID: 23400986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.